News
The mitochondrion plays critical roles in cellular function, making it a prime organelle to target for fundamental studies, ...
The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...
Gene therapy has emerged as a promising approach to previously untreatable conditions, including Duchenne muscular dystrophy (DMD), a progressive disorder caused by DMD mutations that leads to early ...
Learn how AI in drug discovery is revolutionizing therapeutic development and addressing challenges in cell and gene therapy.
Vector BioMed (VBM), a leading lentiviral vector CDMO advancing access to gene therapies, will showcase its innovations at two major industry events this May: the International Society for Cell & Gene ...
Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...
A team of researchers from the Keck School of Medicine of USC has developed an advanced tool for analyzing chimeric antigen ...
This useful study explores the role of RAP2A in asymmetric cell division (ACD) regulation in glioblastoma stem cells (GSCs), drawing parallels to Drosophila ACD mechanisms and proposing that an ...
Biomanufacturers producing protein biologics including complex modalities, will have access to a full suite of custom cell ...
Title: Characterization of KRIYA-839, an AAV-based Gene Therapy Providing Insulin and Glucokinase, in Streptozotocin-induced Diabetic Mice, B. Burch et al. (Poster Abstract 504) Date: May 13, 2025 ...
VectorY Therapeutics (VectorY), a biotechnology company developing innovative vectorized antibody therapies for the treatment of neurodegenerative diseases, today announced that it will have four feat ...
Viral Vector Manufacturing Facility Pty Ltd (VVMF) has selected SYSPRO for its Cloud ERP system. VVMF is Australia’s first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results